Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Thompson

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
MMWR. Morbidity and Mortality Weekly Report|January 12, 2023
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|September 1, 2022
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|November 3, 2022
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
Journal of the American Medical Directors Association|October 19, 2016
Prevalence of Antimicrobial Use and Opportunities to Improve Prescribing Practices in U.S. Nursing HomesNicola D Thompson, Lisa LaPlace, Lauren Epstein, et al.
Infection Control and Hospital Epidemiology|February 8, 2013
Evaluating the accuracy of sampling to estimate central line-days: simplification of the National Healthcare Safety Network surveillance methodsNicola D Thompson, Jonathan R Edwards, Wendy Bamberg, et al.
American Journal of Infection Control|May 26, 2015
Estimating central line-associated bloodstream infection incidence rates by sampling of denominator data: A prospective, multicenter evaluationNicola D Thompson, Jonathan R Edwards, Wendy Bamberg, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Nature Communications|January 20, 2026
Preventing premature deaths through polygenic risk scoresMelisa Chuong, Deborah Thompson, Michael E Weale, et al.
Infection Control and Hospital Epidemiology|June 1, 2017
Measuring Antibiotic Appropriateness for Urinary Tract Infections in Nursing Home ResidentsTaniece Eure, Lisa L LaPlace, Richard Melchreit, et al.
MMWR. Morbidity and Mortality Weekly Report|July 14, 2022
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
MMWR. Morbidity and Mortality Weekly Report|January 12, 2023
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|September 1, 2022
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|November 3, 2022
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
Journal of the American Medical Directors Association|October 19, 2016
Prevalence of Antimicrobial Use and Opportunities to Improve Prescribing Practices in U.S. Nursing HomesNicola D Thompson, Lisa LaPlace, Lauren Epstein, et al.
Infection Control and Hospital Epidemiology|February 8, 2013
Evaluating the accuracy of sampling to estimate central line-days: simplification of the National Healthcare Safety Network surveillance methodsNicola D Thompson, Jonathan R Edwards, Wendy Bamberg, et al.
American Journal of Infection Control|May 26, 2015
Estimating central line-associated bloodstream infection incidence rates by sampling of denominator data: A prospective, multicenter evaluationNicola D Thompson, Jonathan R Edwards, Wendy Bamberg, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Nature Communications|January 20, 2026
Preventing premature deaths through polygenic risk scoresMelisa Chuong, Deborah Thompson, Michael E Weale, et al.
Infection Control and Hospital Epidemiology|June 1, 2017
Measuring Antibiotic Appropriateness for Urinary Tract Infections in Nursing Home ResidentsTaniece Eure, Lisa L LaPlace, Richard Melchreit, et al.
MMWR. Morbidity and Mortality Weekly Report|July 14, 2022
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Pageof 14